| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.069 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |